New antibody-chemo combo shows promise for mesothelioma
Disease control
Completed
This study tested a new drug called PM8002, which targets two proteins that help cancer grow, combined with standard chemotherapy. It involved 31 adults with a rare cancer called malignant mesothelioma that could not be removed by surgery. The goal was to see if the combination s…
Phase: PHASE2 • Sponsor: Biotheus Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC